Düşük doz Methotrexatın indüklediği Henoch-Schönlein Purpurası
Metotreksat (MTX), çeşitli malignite ve kronik inflamatuvar hastalıkların tedavisinde kullanılan
antiproliferatif bir folik asit antagonistidir. Düsük doz, haftalık MTX tedavisi alan hastalarda sık görülen yan
etkiler bulantı ve stomatittir. Henoch-Schönlein purpurası (HSP) genellikle, infeksiyon ajanları, soğuk,
böcek ısırması, besinler veya ilaçlara bağlı olarak tetiklenir. Bu yazıda juvenil idiyopatik artrite yönelik
düşük doz metotrexate başlanan 14 yaşındaki erkek hastada tedavinin 3. haftasında ortaya çıkan HSP
literatür eşliğinde sunulmuştur.
Henoch-Schönlein Purpura induced by Low-Dose Methotrexate
Methotrexate (MTX) is an antiproliferative folic acid antagonist used in the treatment of various malignancies and chronic inflammatory diseases. Commonly observed side effects in patients receiving lowdose, weekly MTX treatment are nausea and stomatitis. Henoch-Schönlein purpura (HSP) is a condition generally induced by infectious agents, exposure to cold, insect bites, foods, and drugs. In this paper, we presented together with a review of the literature a case of HSP that developed in the third week of treatment of a 14-year-old male patient started on low-dose methotrexate for juvenile idiopathic arthritis.
___
- 1) MacGinnitie AJ, Walensky LD, Turvey SE.
Management of an anaphylactoid reaction to
methotrexate with a stepwise graded challenge. Pediatr
Allergy Immunol 2003;14 (2):409-11.
2) Goerttler E, Kutzner H, Peter HH, Requena L.
Methotrexate-induced papular eruption in patients with
rheumatic diseases: a distinctive adverse cutaneous
reaction produced by methotrexate in patients with
collagen vascular diseases. J Am Acad Dermatol
1999;40 (3):702-7.
3) Ozen S. The spectrum of vasculitis in children. Best
Pract Res Clin Rheumatol 2002;16 (5):411-25.
4) Tizard EJ. Henoch-Schönlein purpura. Arch Dis Child
1999;80/3):380-83.
5) Bruce N Cronstein, MD.The mechanism of action of
methotrexate. Rheum Dis Clin N Amer 1997; 23 (2):739-
55.
6) Van Ede AE, Laan RFJM,. Rood MJ et al. Effects of
folic or folinic acid supplementation on the toxicity and
efficacy of methotrexate in rheumatoid arthritis. Arthritis
Rheumatism 2001;44 (3):1515-24.
7) Masuda M, Nakanishi K, Yoshizawa N. Group A
streptococcal antigen in the glomeruli of children with
Henoch-Schonlein nephritis. Am J Kidney Dis 2003;41
(3):366-70.
8) Edekmann CM Jr, Bernstein J, Meadow SR, Spitter A,
Travis LB. Schonlein-Henoch Syndrome. In: Pediatric
Kidney Disease, (2nd edition), Little, Brown and Company
1992;1525-33.
9) Ozlem A, Birsev K. Intoxication Due to High Dose
Methotrexate in a Patient with Rheumatoid Arthritis: ACase
Report. Turk J Rheumatol 2011;26(1):58-60.